Agenda

Saturday, January 27, 2018
7:00 AM - 8:00 AM Registration, buffet breakfast, and exhibits
8:00 AM - 8:10 AM Welcome
Hope S. Rugo, MD,
Professor of Medicine Division of Hematology and Oncology Director, Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, CA
8:10 AM - 8:40 AM Updates in the treatment of HER2+ disease
Sara Hurvitz, MD
Assistant Professor of Medicine Division of Hematology and Oncology Director of Breast Cancer Clinical Research Program David Geffen School of Medicine University of California, Los Angeles, CA
8:40 AM - 9:10 AM Optimal treatment of hormone receptor positive disease
Jo Chien, MD,
Associate Professor of Medicine UCSF School of Medicine Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, CA
9:10 AM - 9:40 AM Immunotherapy for breast cancer
Hope S. Rugo, MD,
Professor of Medicine Division of Hematology and Oncology Director, Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, CA
9:40 AM - 9:55 AM Panel Q and A
9:55 AM - 10:20 AM BREAK
10:20 AM - 10:50 AM Novel therapeutics for advanced breast cancer (not including immunotherapy)
Melinda L. Telli, MD,
Assistant Professor of Medicine - Oncology Stanford University Medical Center, Stanford, CA
10:50 AM - 11:20 AM Advances in approaches to local-regional disease
Michael D. Alvarado, MD,
Associate Professor of Surgery Director, Breast Surgery Oncology Fellowship University of California, San Francisco, CA
11:20 AM - 11:30 AM Q and A
11:30 AM - 12:00 PM Insights in prevention, symptom management and survivorship
Virginia G. Kaklamani, MD, DSc,
Professor of Medicine Ruth McLean Bowman Bowers Chair in Breast Cancer Research and Treatment A.B, University of Alexander Distinguished Chair in Oncology, Associate Director for Clinical Research Leader, Breast Oncology Program CTRC, University of Texas Health Science Center San Antonio, San Antonio, TX
12:00 PM - 12:30 PM New directions in translational research, prognostic markers and resistance mechanisms
Laura J. van ‘t Veer, PhD,
Professor of Laboratory Medicine, Program Leader UCSF Helen Diller Family Comprehensive Cancer Center Breast Oncology Program, University of California, San Francisco, CA
12:30 PM - 12:45 PM Q and A
12:45 PM - 1:00 PM Closing remarks and conclusion
Hope S. Rugo, MD,
Professor of Medicine Division of Hematology and Oncology Director, Breast Oncology Clinical Trials Program, UCSF Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, CA

Any questions? Please email us today.

You are connected to the secure server. You are connected to the secure server.
 
 
 
Registration Powered By eShow